Qtron Investments’s MiMedx Group MDXG Stock Holding History

Qtron Investments’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,962	Closed	-$42K	–	429
2022 Q2	$42K	Buy	+11,962	New	+$46.8K	0.01%	396

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qtron Investments's MDXG Position: Q3 2022 in Review

Qtron Investments sold out of MiMedx Group (MDXG) in Q3 2022, closing a stake of 11,962 shares — an estimated $42K sold.

Qtron Investments first reported a position in MDXG in Q2 2022 and held it in 1 quarter. The position peaked at $42K in Q2 2022. 144 funds tracked by Wall St. Rank hold MDXG as of Q3 2022.

Qtron Investments reported no remaining MiMedx Group position as of Q3 2022 after selling out during the quarter.
Qtron Investments sold 11,962 MiMedx Group shares in Q3 2022, an estimated $42K.
Qtron Investments first reported a position in MiMedx Group in Q2 2022 and held it in 1 quarter.
Qtron Investments's MiMedx Group position peaked at $42K in Q2 2022.
144 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2022.

Based on Qtron Investments's 13F filing for Q3 2022, filed 14 Nov 2022.